Trial intelligence / Profile preview

ASIS for Enbrel in Plaque Psoriasis

NCT02112097Phase 2Unknown

Start
Jan 2016
Primary completion
Jun 2016
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 2 trial of etanercept in plaque psoriasis. Status: unknown.

02

Drugs

etanercept
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT02112097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02112097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call